Measures of Distinction
| High Volume (2016-2019) |
|---|
| As a top 5 high-volume center, we performed: |
| 2,907 Pediatric and Adult Congenital Heart surgeries |
| 104 Pediatric Heart Transplants |
| 5,246 Total Pediatric and Adult Cardiac Catheterization Cases |
| Complex Cases (2016–2019) |
|---|
| 700 STAT 4 and 5 Complex Cases (95.4% and 94.4% survival; STS benchmark, 93.6% and 86.0%) |
| 73 Norwood Cases (92.6% survival; STS benchmark, 85.6%) |
| 545 Neonatal Cardiac Surgeries |
| 180 180 Neonatal Cardiac Catheterization Cases |
| Superior Outcomes (July 2016–June 2020) |
|---|
| 97.4% Survival Rate After ASO and ASO with VSD repair (STS Benchmark, 97%) |
| 98.9% Survival Rate After Glenn/Fontan Procedure (STS Benchmark, 98%) |
| 100% Survival Rate After Fontan Procedure (STS Benchmark, 99%) |
| 90.5% Survival Rate After Norwood Procedure (STS Benchmark, 86.4%) |
| 100% 1-Month and 94.8% 1-Year Survival Rate After Pediatric Heart Transplant (SRTR Benchmark, 97.6% and 92.3%) |
| Expert Care (2019) |
|---|
| 7 Congenital Heart Doctors Listed in New York magazine’s Best Doctor’s |
| 4 Pediatric Cardiologists Certified in Adult Congenital Heart Disease |
| 6 Congenital Interventional Cardiologists |
| 15 Pediatric Cardiology Fellows and 2 Advanced 4th Year Fellows (1 in Pediatric Heart Failure, Transplant and Cardiomyopathy; 1 in Pediatric Non-Invasive Imaging) |
| 2 Pediatric Cardiac Surgery Instructors |
| 3 Attending Surgeons |
| 1 Cardiac Surgery Resident |